Atherosclerotic renovascular disease as a cause of end-stage renal disease: Cost considerations

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Atherosclerotic vascular disease affects an increasing number of patients with end-stage renal disease. A review of comorbid atherosclerotic disease in 7,200 end-stage renal disease patients indicated that occlusive disease of the renal arteries may contribute to progressive renal failure in 1.34% of the US dialysis population or in 14% of the Caucasian patients with hypertensive nephrosclerosis. The costs of dialytic care in such patients exceed USD 87 million annually. The risks and costs of surgical revascularization of such patients are large, however. These data argue that prospective trials of intervention in atherosclerotic renal artery disease are urgently needed.

Original languageEnglish (US)
Pages (from-to)305-314
Number of pages10
JournalBlood Purification
Volume14
Issue number4
StatePublished - Jul 1996

Fingerprint

Cost of Illness
Chronic Kidney Failure
Renal Artery
Nephrosclerosis
Costs and Cost Analysis
Vascular Diseases
Renal Insufficiency
Dialysis
Population

Keywords

  • Atherosclerosis
  • End-stage renal disease
  • Hypertension
  • Ischemic nephropathy
  • Renal artery stenosis
  • Renovascular disease

ASJC Scopus subject areas

  • Nephrology
  • Hematology

Cite this

Atherosclerotic renovascular disease as a cause of end-stage renal disease : Cost considerations. / Textor, Stephen C.

In: Blood Purification, Vol. 14, No. 4, 07.1996, p. 305-314.

Research output: Contribution to journalArticle

@article{61ddc67b8bfd412a8c943af4cc7e4408,
title = "Atherosclerotic renovascular disease as a cause of end-stage renal disease: Cost considerations",
abstract = "Atherosclerotic vascular disease affects an increasing number of patients with end-stage renal disease. A review of comorbid atherosclerotic disease in 7,200 end-stage renal disease patients indicated that occlusive disease of the renal arteries may contribute to progressive renal failure in 1.34{\%} of the US dialysis population or in 14{\%} of the Caucasian patients with hypertensive nephrosclerosis. The costs of dialytic care in such patients exceed USD 87 million annually. The risks and costs of surgical revascularization of such patients are large, however. These data argue that prospective trials of intervention in atherosclerotic renal artery disease are urgently needed.",
keywords = "Atherosclerosis, End-stage renal disease, Hypertension, Ischemic nephropathy, Renal artery stenosis, Renovascular disease",
author = "Textor, {Stephen C}",
year = "1996",
month = "7",
language = "English (US)",
volume = "14",
pages = "305--314",
journal = "Blood Purification",
issn = "0253-5068",
publisher = "S. Karger AG",
number = "4",

}

TY - JOUR

T1 - Atherosclerotic renovascular disease as a cause of end-stage renal disease

T2 - Cost considerations

AU - Textor, Stephen C

PY - 1996/7

Y1 - 1996/7

N2 - Atherosclerotic vascular disease affects an increasing number of patients with end-stage renal disease. A review of comorbid atherosclerotic disease in 7,200 end-stage renal disease patients indicated that occlusive disease of the renal arteries may contribute to progressive renal failure in 1.34% of the US dialysis population or in 14% of the Caucasian patients with hypertensive nephrosclerosis. The costs of dialytic care in such patients exceed USD 87 million annually. The risks and costs of surgical revascularization of such patients are large, however. These data argue that prospective trials of intervention in atherosclerotic renal artery disease are urgently needed.

AB - Atherosclerotic vascular disease affects an increasing number of patients with end-stage renal disease. A review of comorbid atherosclerotic disease in 7,200 end-stage renal disease patients indicated that occlusive disease of the renal arteries may contribute to progressive renal failure in 1.34% of the US dialysis population or in 14% of the Caucasian patients with hypertensive nephrosclerosis. The costs of dialytic care in such patients exceed USD 87 million annually. The risks and costs of surgical revascularization of such patients are large, however. These data argue that prospective trials of intervention in atherosclerotic renal artery disease are urgently needed.

KW - Atherosclerosis

KW - End-stage renal disease

KW - Hypertension

KW - Ischemic nephropathy

KW - Renal artery stenosis

KW - Renovascular disease

UR - http://www.scopus.com/inward/record.url?scp=0029765538&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029765538&partnerID=8YFLogxK

M3 - Article

C2 - 8873956

AN - SCOPUS:0029765538

VL - 14

SP - 305

EP - 314

JO - Blood Purification

JF - Blood Purification

SN - 0253-5068

IS - 4

ER -